尖锐湿疣治疗专家共识(2017)

2018-02-20 中华医学会皮肤性病学分会 临床皮肤科杂志.2018,47(2):125-127.

尖锐湿疣是由人乳头瘤病毒(HPV)感染引起的性传播疾病,目前的治疗主要以去除疣体及HPV 感染组织为主,包括医院外治疗及医院内治疗。现阶段尚没有一种理想的治疗方法可以有效解决复发问题,需根据疣体大小、数目、部位和形态,并充分考虑患者年龄、个体差异和依从性,兼顾特殊人群,选择个体化治疗方案,采取综合防治策略,达到最满意的疗效。

中文标题:

尖锐湿疣治疗专家共识(2017)

发布日期:

2018-02-20

简要介绍:

尖锐湿疣是由人乳头瘤病毒(HPV)感染引起的性传播疾病,目前的治疗主要以去除疣体及HPV 感染组织为主,包括医院外治疗及医院内治疗。现阶段尚没有一种理想的治疗方法可以有效解决复发问题,需根据疣体大小、数目、部位和形态,并充分考虑患者年龄、个体差异和依从性,兼顾特殊人群,选择个体化治疗方案,采取综合防治策略,达到最满意的疗效。

 

拓展指南:尖锐湿疣相关指南:

下载附件:

(因为版权问题,不支持下载)

评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=958788, encodeId=47aa958e8867, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c93c5478886, createdName=ms4000001381358594, createdTime=Tue Apr 20 16:44:52 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956542, encodeId=d316956542e0, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d341413483, createdName=yuxuepiao, createdTime=Tue Apr 13 13:20:42 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921833, encodeId=65749218337e, content=哇!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29535177825, createdName=146edeb7m12暂无昵称, createdTime=Mon Feb 01 08:52:44 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907863, encodeId=3b3f90e863b0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201214/d2827d554c994cb0b95a1a7bba796089/702dffcc40df4000a3402c899d2f8d2c.jpg, createdBy=8dd85234914, createdName=鄢小君, createdTime=Mon Dec 14 16:12:09 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807648, encodeId=50fd80e6488e, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f252253874, createdName=1216e818m08暂无昵称, createdTime=Wed Aug 12 09:31:30 CST 2020, time=2020-08-12, status=1, ipAttribution=)]
    2021-04-20 ms4000001381358594

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=958788, encodeId=47aa958e8867, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c93c5478886, createdName=ms4000001381358594, createdTime=Tue Apr 20 16:44:52 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956542, encodeId=d316956542e0, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d341413483, createdName=yuxuepiao, createdTime=Tue Apr 13 13:20:42 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921833, encodeId=65749218337e, content=哇!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29535177825, createdName=146edeb7m12暂无昵称, createdTime=Mon Feb 01 08:52:44 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907863, encodeId=3b3f90e863b0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201214/d2827d554c994cb0b95a1a7bba796089/702dffcc40df4000a3402c899d2f8d2c.jpg, createdBy=8dd85234914, createdName=鄢小君, createdTime=Mon Dec 14 16:12:09 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807648, encodeId=50fd80e6488e, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f252253874, createdName=1216e818m08暂无昵称, createdTime=Wed Aug 12 09:31:30 CST 2020, time=2020-08-12, status=1, ipAttribution=)]
    2021-04-13 yuxuepiao

    谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=958788, encodeId=47aa958e8867, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c93c5478886, createdName=ms4000001381358594, createdTime=Tue Apr 20 16:44:52 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956542, encodeId=d316956542e0, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d341413483, createdName=yuxuepiao, createdTime=Tue Apr 13 13:20:42 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921833, encodeId=65749218337e, content=哇!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29535177825, createdName=146edeb7m12暂无昵称, createdTime=Mon Feb 01 08:52:44 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907863, encodeId=3b3f90e863b0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201214/d2827d554c994cb0b95a1a7bba796089/702dffcc40df4000a3402c899d2f8d2c.jpg, createdBy=8dd85234914, createdName=鄢小君, createdTime=Mon Dec 14 16:12:09 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807648, encodeId=50fd80e6488e, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f252253874, createdName=1216e818m08暂无昵称, createdTime=Wed Aug 12 09:31:30 CST 2020, time=2020-08-12, status=1, ipAttribution=)]
    2021-02-01 146edeb7m12暂无昵称

    哇!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=958788, encodeId=47aa958e8867, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c93c5478886, createdName=ms4000001381358594, createdTime=Tue Apr 20 16:44:52 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956542, encodeId=d316956542e0, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d341413483, createdName=yuxuepiao, createdTime=Tue Apr 13 13:20:42 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921833, encodeId=65749218337e, content=哇!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29535177825, createdName=146edeb7m12暂无昵称, createdTime=Mon Feb 01 08:52:44 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907863, encodeId=3b3f90e863b0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201214/d2827d554c994cb0b95a1a7bba796089/702dffcc40df4000a3402c899d2f8d2c.jpg, createdBy=8dd85234914, createdName=鄢小君, createdTime=Mon Dec 14 16:12:09 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807648, encodeId=50fd80e6488e, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f252253874, createdName=1216e818m08暂无昵称, createdTime=Wed Aug 12 09:31:30 CST 2020, time=2020-08-12, status=1, ipAttribution=)]
    2020-12-14 鄢小君

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=958788, encodeId=47aa958e8867, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c93c5478886, createdName=ms4000001381358594, createdTime=Tue Apr 20 16:44:52 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956542, encodeId=d316956542e0, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d341413483, createdName=yuxuepiao, createdTime=Tue Apr 13 13:20:42 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921833, encodeId=65749218337e, content=哇!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29535177825, createdName=146edeb7m12暂无昵称, createdTime=Mon Feb 01 08:52:44 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907863, encodeId=3b3f90e863b0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201214/d2827d554c994cb0b95a1a7bba796089/702dffcc40df4000a3402c899d2f8d2c.jpg, createdBy=8dd85234914, createdName=鄢小君, createdTime=Mon Dec 14 16:12:09 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807648, encodeId=50fd80e6488e, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f252253874, createdName=1216e818m08暂无昵称, createdTime=Wed Aug 12 09:31:30 CST 2020, time=2020-08-12, status=1, ipAttribution=)]
    2020-08-12 1216e818m08暂无昵称

    学习了,谢谢分享

    0